Literature DB >> 12149658

Blood rheology in men with essential hypertension and capillary rarefaction.

G Ciuffetti1, L Pasqualini, M Pirro, R Lombardini, M De Sio, G Schillaci, E Mannarino.   

Abstract

The pathophysiological significance of hyperviscosity and capillary rarefaction in untreated essential hypertension is unknown. Fifty untreated hypertensive men with capillary rarefaction (intravital capillaroscopy) and 20 age- and sex-matched normotensive controls underwent full haemorheological profiling (blood viscosity at high and low shear, haematocrit, platelet and leukocyte counts, fibrinogen and total protein concentrations, P-selectin levels, erythrocyte and leukocyte filterability rates and erythrocyte deformability and aggregation indexes). Subjects with skin capillary density below the group median had younger age, higher diastolic pressure, higher blood viscosity at low shear, higher P-selectin levels, higher erythrocyte and leukocyte filterability rates, and higher erythrocyte aggregation indexes (all P < 0.01). In contrast, patients with greater skin capillary density had a greater plasma viscosity (P < 0.05). The conclusions were that in untreated hypertensive men, capillary rarefaction and hyperviscosity are associated to an increased diastolic blood pressure and to an adverse haemorheological profile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149658     DOI: 10.1038/sj.jhh.1001454

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  9 in total

1.  Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats.

Authors:  Mark B Plotnikov; Oleg I Aliev; Aleksandr Y Shamanaev; Anastasia V Sidekhmenova; Anna M Anishchenko; Tatiana I Fomina; Victoria S Rydchenko; Andrei I Khlebnikov; Yana J Anfinogenova; Igor A Schepetkin; Dmitriy N Atochin
Journal:  Hypertens Res       Date:  2020-05-07       Impact factor: 3.872

Review 2.  Is endothelial progenitor cell dysfunction involved in altered angiogenic processes in patients with hypertension?

Authors:  Cindy J M Loomans; Huy H Dao; Anton J van Zonneveld; Ton J Rabelink
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

3.  The GG genotype of the -152 G/A vascular endothelial growth factor (VEGF) polymorphism predisposes to hypertension-related chronic kidney disease.

Authors:  Anna Małkiewicz; Maria Skrzypkowska; Bartosz Słomiński; Janusz Siebert; Piotr Gutknecht; Jolanta Myśliwska
Journal:  Mol Biol Rep       Date:  2016-07-06       Impact factor: 2.316

Review 4.  The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension.

Authors:  Amani M Norling; Adam T Gerstenecker; Thomas W Buford; Bilal Khan; Suzanne Oparil; Ronald M Lazar
Journal:  Geroscience       Date:  2019-12-05       Impact factor: 7.713

5.  Hemodynamic and morphological vasculature response to a burn monitored using a combined dual-wavelength laser speckle and optical microangiography imaging system.

Authors:  Jia Qin; Roberto Reif; Zhongwei Zhi; Suzan Dziennis; Ruikang Wang
Journal:  Biomed Opt Express       Date:  2012-02-09       Impact factor: 3.732

6.  Hemorheological effects of amlodipine in spontaneously hypertensive rats.

Authors:  Aleksandr Y Shamanaev; Oleg I Aliev; Anna M Anishchenko; Anastasia V Sidehmenova; Mark B Plotnikov
Journal:  Indian J Pharmacol       Date:  2017 Jul-Aug       Impact factor: 1.200

7.  Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms.

Authors:  Raunak Rao; Spoorthy Kulkarni; Ian B Wilkinson
Journal:  Case Rep Vasc Med       Date:  2020-11-09

8.  Hypertension from the perspective of Iranian traditional medicine.

Authors:  Roshanak Ghods; Manouchehr Gharooni; Gholamreza Amin; Esmaeil Nazem; Alireza Nikbakht Nasrabadi
Journal:  Iran Red Crescent Med J       Date:  2014-03-05       Impact factor: 0.611

Review 9.  Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging.

Authors:  Meredith Hay; Carol Barnes; Matt Huentelman; Roberta Brinton; Lee Ryan
Journal:  Curr Hypertens Rep       Date:  2020-09-03       Impact factor: 5.369

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.